GSTM1 and anemia: The updated guidelines from ECCO advise that first line treatment should be IV iron in patients with active IBD, severe anaemia (Hb < 100 g/L), if previously intolerant to oral iron and for patients in need of concomitant treatment with erythropoietin (Epo) [20].